A Multicenter Phase II Study of Vaccines to Prevent Recurrence in Patients with HER-2 Positive Breast Cancer
The main purpose of this study is to evaluate the safety of each investigational study vaccine and to evaluate the effect on the time to disease recurrence (assessed by disease free survival).
- IRB Number: 1901224259 (MCC19117)
- Research Study Identifier: TX10535
- Principal Investigator: Carla Fisher, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required